Explore more publications!

World Wellness Times: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on World Wellness Times.

Press releases published on December 6, 2025

Caring Therapists Expands to Port Orange with Lakeside Counseling and Wellness Center Partnership
Seven Corbett Announces Exclusive 2026 New Year Trip Package in Jim Corbett
Oriental Artisan Elevates Corporate Gifting with Curated Collection of Handcrafted Eastern Treasures
J-POWER: Redefining Home Fitness with Patented Power and Global Ambition
Top 10 Treadmills for Home Use 2025 — Famistar T532 Among the Best
How to Get Started with Reformer Pilates in Jeddah: KARVE's Approach to Making Movement a Lifestyle
Dr. Kevin Miller Selected as Top Global Communications and Healthcare Executive of the Decade by IAOTP
Natural Food Preservatives Market Size, Share, Rising Trends, Industry Demand and Revenue Outlook
Fulcrum Therapeutics Announces Positive Initial Results from the 20 mg Dose Cohort of the Phase 1b PIONEER Trial of Pociredir in Sickle Cell Disease at the 67th American Society of Hematology Annual Meeting
TScan Therapeutics Announces Positive Updated Data from the ALLOHA™ Phase 1 Heme Trial at the 67th American Society of Hematology Annual Meeting and Exposition
Aquafeed Market Trends, Growth Analysis, and Future Outlook | 2024-2034
Green Terror, Tom Green to Outfit Graduating Seniors with Suits
Sapu Nano 宣布推出基于 Deciparticle™ 技术的生物标志物框架,用于识别最可能对静脉注射 Sapu003(一种依维莫司纳米药物)产生反应的肿瘤
Sapu Nano 宣佈由 Deciparticle™ 驅動的生物標記框架,可識別出最有可能對靜脈注射依維莫司納米藥物 Sapu003 產生反應的腫瘤
BioNTechs und OncoC4s selektiver Treg-Modulatorkandidat Gotistobart erzielte klinisch relevanten Gesamtüberlebensvorteil bei Patientinnen und Patienten mit zuvor behandeltem Plattenepithelkarzinom der Lunge
BioNTech and OncoC4 Announce Clinically Meaningful Overall Survival Benefit for Selective Treg Modulator Gotistobart in Patients with Previously Treated Squamous Non-Small Cell Lung Cancer
Remedy's Nutrition® Launches Cyst-Be-Gone™ — Advanced Herbal Formula to Support Natural Cyst & Tissue Wellness
Evaxion presents new data for EVX-04, a cancer vaccine candidate for acute myeloid leukemia at ASH Annual Meeting
Legend Biotech Highlights New CARVYKTI® Data in Multiple Myeloma and First-in-Human Results from Novel CAR-T Platform in Non-Hodgkin Lymphoma at ASH 2025
Prelude Therapeutics Presents Data at the 2025 ASH Annual Meeting from its Myeloproliferative Neoplasm (MPN) Programs

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions